Gonçalves, L.; Gonçalves, D.; Esteban-Casanelles, T.; Barroso, T.; Soares de Pinho, I.; Lopes-Brás, R.; Esperança-Martins, M.; Patel, V.; Torres, S.; Teixeira de Sousa, R.;
et al. Immunotherapy around the Clock: Impact of Infusion Timing on Stage IV Melanoma Outcomes. Cells 2023, 12, 2068.
https://doi.org/10.3390/cells12162068
AMA Style
Gonçalves L, Gonçalves D, Esteban-Casanelles T, Barroso T, Soares de Pinho I, Lopes-Brás R, Esperança-Martins M, Patel V, Torres S, Teixeira de Sousa R,
et al. Immunotherapy around the Clock: Impact of Infusion Timing on Stage IV Melanoma Outcomes. Cells. 2023; 12(16):2068.
https://doi.org/10.3390/cells12162068
Chicago/Turabian Style
Gonçalves, Lisa, Duarte Gonçalves, Teresa Esteban-Casanelles, Tiago Barroso, Inês Soares de Pinho, Raquel Lopes-Brás, Miguel Esperança-Martins, Vanessa Patel, Sofia Torres, Rita Teixeira de Sousa,
and et al. 2023. "Immunotherapy around the Clock: Impact of Infusion Timing on Stage IV Melanoma Outcomes" Cells 12, no. 16: 2068.
https://doi.org/10.3390/cells12162068
APA Style
Gonçalves, L., Gonçalves, D., Esteban-Casanelles, T., Barroso, T., Soares de Pinho, I., Lopes-Brás, R., Esperança-Martins, M., Patel, V., Torres, S., Teixeira de Sousa, R., Mansinho, A., & Costa, L.
(2023). Immunotherapy around the Clock: Impact of Infusion Timing on Stage IV Melanoma Outcomes. Cells, 12(16), 2068.
https://doi.org/10.3390/cells12162068